# Oramed Pharmaceuticals Inc. (ORMP): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Oramed Pharmaceuticals Inc. (ORMP) is 73/100, ranked against 24,000+ stocks in 35 markets (Quality 64, Value 47, Momentum 57, each scored against its sector).

- StockRank: 73/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 64, Value 47, Momentum 57: each a 0-100 percentile within Healthcare.
- Position: #7,261 overall, #748 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 4.08 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 1.2M.
- Buybacks, last 180 days: the company bought back USD 371K on 1 day.

Source: https://moatmap.ai/stock/ORMP
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker